Valuation: Bionime Corporation

Market Cap 442.07Cr 14Cr 12Cr 11Cr 10Cr 20Cr 1.32TCr 20Cr 134.75Cr 52Cr 646.85Cr 52Cr 51Cr 2.25TCr P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 699.44Cr 22Cr 19Cr 18Cr 17Cr 31Cr 2.09TCr 32Cr 213.2Cr 83Cr 1.02TCr 82Cr 81Cr 3.56TCr EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
53.01%
Yield 2024 *
-
Yield 2025 -
1 day+2.88%
1 week-0.52%
Current month+2.88%
1 month+0.18%
3 months-15.63%
6 months-3.87%
Current year-3.87%
1 week 55.6
Extreme 55.6
58
1 month 49.75
Extreme 49.75
59.3
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.1415
81.92
5 years 43.14
Extreme 43.1415
88.92
10 years 40
Extreme 40.0048
88.92
Manager TitleAgeSince
Chief Executive Officer - 09/07/2010
Director of Finance/CFO - 06/11/2017
Chief Tech/Sci/R&D Officer - 07/11/2018
Director TitleAgeSince
Chairman - 14/04/2003
Director/Board Member - 17/10/2007
Director/Board Member - 15/05/2007
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%-0.52%-13.22%-18.72% 14Cr
+13.82%+30.53%+228.15%+377.01% 1.99TCr
+2.04%+5.26%-40.29%-27.07% 925.79Cr
-1.78%+2.76%+33.11%+29.84% 722.29Cr
+5.22%+6.53%-29.83% - 503.74Cr
+4.31%+2.62%-22.76%-25.75% 485.81Cr
+1.85%+22.53%+237.22%-30.07% 486.75Cr
+2.95%+8.22%-23.22%-26.88% 410.3Cr
-1.64%+0.77%+90.83%+97.44% 435.41Cr
+3.03%-3.24%-20.27%-42.20% 244.12Cr
Average +3.27%+5.00%+43.97%+37.07% 621.71Cr
Weighted average by Cap. +5.63%+7.77%+89.23%+129.56%

Financials

2024 2025
Net sales 193.37Cr 6.07Cr 5.33Cr 4.9Cr 4.56Cr 8.61Cr 577.54Cr 8.81Cr 59Cr 23Cr 282.95Cr 23Cr 22Cr 985.61Cr 183.86Cr 5.77Cr 5.06Cr 4.66Cr 4.34Cr 8.19Cr 549.12Cr 8.38Cr 56Cr 22Cr 269.03Cr 22Cr 21Cr 937.11Cr
Net income -13Cr -39.91L -35.04L -32.26L -30.02L -56.67L -38Cr -57.95L -3.88Cr -1.5Cr -19Cr -1.5Cr -1.47Cr -65Cr -18Cr -56.55L -49.66L -45.71L -42.54L -80.3L -54Cr -82.12L -5.5Cr -2.13Cr -26Cr -2.12Cr -2.08Cr -92Cr
Net Debt 278.4Cr 8.73Cr 7.67Cr 7.06Cr 6.57Cr 12Cr 831.48Cr 13Cr 85Cr 33Cr 407.36Cr 33Cr 32Cr 1.42TCr 257.37Cr 8.07Cr 7.09Cr 6.53Cr 6.07Cr 11Cr 768.66Cr 12Cr 78Cr 30Cr 376.59Cr 30Cr 30Cr 1.31TCr
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
01/26/01 NT$57.20 +2.88% 92,320
30/26/30 NT$55.60 -2.80% 1,13,523
29/26/29 NT$57.20 +0.35% 65,872
26/26/26 NT$57.00 -0.18% 1,30,049
25/26/25 NT$57.10 0.00% 66,911

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock